 |
Ori SpotlightAuthor: Ori Biotech
Ori Spotlight covers the latest in cell and gene therapy. Jason C. Foster, Ori Biotech CEO will be talking to leaders from across the industry to find out more about how we can break down the barriers and seize the opportunities to make sure that every patient has access to life-changing treatments. Connect with Ori Biotech to learn more about partnering to pioneer innovative technologies in CGT manufacturing that bring CGT products to market at commercial scale at decreased costs while increasing throughput and improving quality: www.oribiotech.com/connect Language: en Genres: Life Sciences, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Ken Harris: Why AI and automation are CGT’s next inflection point
Tuesday, 27 January, 2026
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Ken Harris, CEO of Omnia Bio and former healthcare lead at Amazon Web Services, to explore what it will take to scale CAR-T from hundreds to millions.Drawing on 35 years in healthcare, Ken shares how AI, automation, and digital infrastructure can help streamline manufacturing and support consistent delivery. They unpack the economic reality behind CGT access, the need for smarter clinical trial design, and why a more integrated system is essential to move beyond bespoke solutions.
